UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Determinants of Maternal Satisfaction with Existing Delivery Care at Wolaita Sodo University Teaching and Referral Hospital, Ethiopia

BioMed research international, 2020, Vol.2020 (2020), p.1-7

2020

Volltextzugriff (PDF)

Fuzzy Multidimensional Model to Cluster Dengue Risk in Sri Lanka

BioMed research international, 2020, Vol.2020 (2020), p.1-16

2020

Volltextzugriff (PDF)

Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications

Clinical & experimental metastasis, 2016-10, Vol.33 (7), p.717-725

2016

Volltextzugriff (PDF)

Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas

BMC cancer, 2019-06, Vol.19 (1), p.556-556, Article 556

2019

Volltextzugriff (PDF)

Nimotuzumab Site-Specifically Labeled with 89Zr and 225Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers

Cancers, 2020-11, Vol.12 (11), p.3449

2020

Volltextzugriff (PDF)

Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity

Molecular cancer therapeutics, 2008-07, Vol.7 (7), p.2033-2041

2008

Volltextzugriff (PDF)

Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer

Journal of Oncology, 2014-01, Vol.2014 (2014), p.61-68

2014

Volltextzugriff (PDF)

UMELISA EGF: un medio para la investigación y el diagnóstico acompañante de terapia personalizada

Anales de la Academia de Ciencias de Cuba, 2023-08, Vol.13 (2)

2023

Volltextzugriff (PDF)

Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer

Pathology Research International, 2012, Vol.2012 (2012), p.73-84

2012

Volltextzugriff (PDF)

Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: Results of a phase Ib/IIa study

Cancer biology & therapy, 2008-04, Vol.7 (4), p.488-495

2008

Volltextzugriff (PDF)

Immunotherapy of Advanced Breast Cancer With a Heterophilic Ganglioside (NeuGcGM3) Cancer Vaccine

Journal of clinical oncology, 2003-03, Vol.21 (6), p.1015-1021

2003

Volltextzugriff (PDF)

Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients

Human vaccines, 2010-09, Vol.6 (9), p.736-744

2010

Volltextzugriff (PDF)

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis

Pathology Research International, 2013, Vol.2013 (2013), p.124-135

2013

Volltextzugriff (PDF)

Abstract B120: Synergistic potentiation of the anti-metastatic effect of anti EGFR mAbs by its combination with immunotherapies targeting the ganglioside NGcGM3

Cancer immunology research, 2016-11, Vol.4 (11_Supplement), p.B120-B120

2016

Volltextzugriff (PDF)

Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3

Oncotarget, 2018-05, Vol.9 (35), p.24069-24080

2018

Volltextzugriff (PDF)

Nimotuzumab Site-Specifically Labeled with [.sup.89]Zr and [.sup.225]Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers

Cancers, 2020-11, Vol.12 (11), p.1

2020

Volltextzugriff (PDF)

Normalized Serum EGF Levels as a Potential Biomarker in Non-Small Cell Lung Cancer: The Role of Platelets

Journal of Molecular Biomarkers & Diagnosis, 2018, Vol.9 (5)

2018

Volltextzugriff (PDF)

Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac

Frontiers in oncology, 2019, Vol.9, p.49

2019

Volltextzugriff (PDF)

Measurement of Serum EGF Levels, a Methodological Approach: Learning What Means “Low-/High-Concentration of EGF In Serum”. Some Clinical Implications

Journal of Molecular Biomarkers & Diagnosis, 2017, Vol.8 (3)

2017

Volltextzugriff (PDF)

Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences

Pathology research international, 2015, Vol.2015, p.132326-12

2015

Volltextzugriff (PDF)

NGcGM3/VSSP vaccine as treatment for melanoma patients

Human vaccines & immunotherapeutics, 2013-06, Vol.9 (6), p.1237-1240

2013

Volltextzugriff (PDF)

An enzyme immunoassay for determining epidermal growth factor (EGF) in human serum samples using an ultramicroanalytical system

Journal of immunoassay & immunochemistry, 2017, Vol.38 (2), p.190-201

2017

Volltextzugriff (PDF)

Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc

Breast cancer research and treatment, 2006-03, Vol.96 (2), p.115-121

2006

Volltextzugriff (PDF)

Gangliosides expressed in human breast cancer

Cancer research (Chicago, Ill.), 1996-11, Vol.56 (22), p.5165-5171

1996

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(81)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Determinants of Maternal Satisfaction with Existing Delivery Care at Wolaita Sodo University Teaching and Referral Hospital, Ethiopia

Fuzzy Multidimensional Model to Cluster Dengue Risk in Sri Lanka

Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications

Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas

Marine Seagrass Extract of Thalassia testudinum Suppresses Colorectal Tumor Growth, Motility and Angiogenesis by Autophagic Stress and Immunogenic Cell Death Pathways

Nimotuzumab Site-Specifically Labeled with 89Zr and 225Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers

Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity

Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer

UMELISA EGF: un medio para la investigación y el diagnóstico acompañante de terapia personalizada

Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer

Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: Results of a phase Ib/IIa study

Immunotherapy of Advanced Breast Cancer With a Heterophilic Ganglioside (NeuGcGM3) Cancer Vaccine

Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis

Abstract B120: Synergistic potentiation of the anti-metastatic effect of anti EGFR mAbs by its combination with immunotherapies targeting the ganglioside NGcGM3

Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3

Nimotuzumab Site-Specifically Labeled with [.sup.89]Zr and [.sup.225]Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers

Normalized Serum EGF Levels as a Potential Biomarker in Non-Small Cell Lung Cancer: The Role of Platelets

Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac

Measurement of Serum EGF Levels, a Methodological Approach: Learning What Means “Low-/High-Concentration of EGF In Serum”. Some Clinical Implications

Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences

NGcGM3/VSSP vaccine as treatment for melanoma patients

An enzyme immunoassay for determining epidermal growth factor (EGF) in human serum samples using an ultramicroanalytical system

Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc

Gangliosides expressed in human breast cancer

Suchergebnisse filtern